ARENSIA, a German company with 700 employees across eight countries, has established a unique and efficient infrastructure, operating 14 proprietary research clinics in Europe and the USA. Unlike traditional clinical trial sites that often face challenges such as overcrowded hospitals, staff shortages, lengthy contract negotiations, and difficulties in achieving recruitment targets, ARENSIA’s model of professional Phase I patient clinics is designed to overcome these hurdles.